Drawing for NEARMEDIC

USPTO serial 79169033

NEARMEDIC

Reviewed by CopyMark Law Group

Reg. 4966868Status 404
Filing date
Status date
Registration date
May 31, 2016
Examiner
STRUCK, ROBERT J
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEARMEDIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry; chemicals used in science; carbonic hydrates; albumin for industrial purposes; animal albumen for industrial purposes; chemicals for use in industry, namely, cellulose derivatives; chemical reagents, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposesSECTION 71 - CANCELLED—
005Pharmaceutical preparations including cell-based preparations for medical purposes including stem cells for the treatment of endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biocides; biological preparations for medical purposes for the prevention and treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; medicines for human purposes for the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; albuminous preparations for medical purposes for the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; stem cells for medical purposes; surgical dressings; diagnostic preparations for medical purposes; chemical preparations for medical purposes for the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biological tissue cultures for medical purposesSECTION 71 - CANCELLED—
010Medical apparatus and instruments for treating cardiovascular, infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases; testing apparatus for medical purposes in the field cancer, hepatology, ophthalmology, gastroenterology, hematology, dermatology, neurology, immunology, and infectious diseases; suture materials; surgical thread; surgical implants comprised of artificial materials; cell implants consisting of artificial materialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 5, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 5, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 16, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 18, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 15, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 16, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 16, 2022C71TCANCELLED SECTION 71—
May 31, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Apr 28, 2017FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 1, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 1, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Aug 31, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 31, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 15, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 15, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2016GPNXNOTIFICATION PROCESSED BY IB—
Feb 24, 2016OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 24, 2016OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 29, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 25, 2016TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 25, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 25, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 25, 2016TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 15, 2015RFNTREFUSAL PROCESSED BY IB—
Jul 28, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 28, 2015RFRRREFUSAL PROCESSED BY MPU—
Jul 28, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 27, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jul 20, 2015DOCKASSIGNED TO EXAMINER—
Jul 20, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 16, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance